今年4月7日，受外部因素影响，高视医疗(02407)股价大幅下跌，单日跌幅达到15.99%。而后，公司股价开启缓慢爬升过程，5月7日，公司收盘价6.05港元， 已超过4月6日收盘价，宣告高视医疗正式修复此轮行情跌幅。 然而，拉长时间线来看，高视医疗整个4月份的股价跌幅依旧达到3.53%，相比之下恒生医疗保健板块的同期涨幅为1.10%。跑输板块的背后，或许与高视医 疗被踢出港股通以及2024年年报业绩表现不佳有关。 在大市震荡前被踢出港股通 回顾4月份，受外部环境因素负面影响，恒指4月7日在长假期后复市大跌13.2%，指数暴泻3021点，创下自亚洲金融危机以来最大单日跌幅，恒生医疗保健 指数当日也暴跌了19.01%，指数跌至2408.11点。 按照规则，被踢出港股通后，投资者只能继续持有或单向卖出。很显然，港股通资金并未在高视医疗上过多停留，截至5月7日，公司"出通"后股价累跌 25.22%。随着公司股价一路下滑，其港股通持股比例也降至5月7日的5.94%。 但仅过去10个交易日，恒生医疗保健指数便在盘中触及2978.74点，跃过4月6日收盘价成功"收复失地"，反弹表现明显较高视医疗更佳，究其原因在于南向 资金 ...

F # CGS 预调酒韧性发展,威士忌销售起步 2024 年度和 2025Q1 业绩点评 核心观点 主要财务指标预测 | | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业收入(百万元) | 3048.13 | 3749.29 | 4628.63 | 5574.47 | | 收入增长率% | -6.61 | 23.00 | 23.45 | 20.43 | | 归母净利润(百万元) | 719.14 | 806.64 | 1051.92 | 1358.54 | | 利润增速% | -11.15 | 12.17 | 30.41 | 29.15 | | 毛利率% | 69.67 | 71.17 | 72.12 | 73.08 | | 摊薄 EPS(元) | 0.69 | 0.77 | 1.00 | 1.29 | | PE | 40.87 | 33.95 | 26.04 | 20.16 | | PB | 6.27 | 5.40 | 4.71 | 4.05 | | PS | 8.99 | 7.30 | 5.92 | 4.91 | ...

Core Viewpoint - Aflac Incorporated reported weaker-than-expected first-quarter 2025 results, with adjusted earnings per share (EPS) of $1.66, missing estimates by 1.2%, while revenues decreased to $4.3 billion, missing consensus by 1.3% [1][2] Financial Performance - Adjusted net investment income decreased by 2.2% year over year to $913 million [3] - Total net benefits and claims declined by 3.2% year over year to $1.9 billion [3] - Total acquisition and operating expenses increased by 4.1% year over year to $1.3 billion [3] - Pre-tax earnings plummeted by 93.3% year over year to $145 million [3] Segment Analysis - **Aflac Japan**: Adjusted revenues decreased by 8.1% year over year to $2.3 billion, missing estimates by 5.3%. Total net earned premiums dipped by 7.4% year over year to $1.7 billion [4] - **Aflac U.S.**: Adjusted revenues increased by 1.3% year over year to $1.7 billion, but missed estimates by 1.4%. Total net earned premiums climbed by 1.8% year over year to $1.4 billion [6] Investment and Capital Management - Aflac bought back 8.5 million shares worth $900 million in the first quarter, with 38.8 million shares remaining for buyback [11] - The company announced a dividend of 58 cents per share for the second quarter, payable on June 2, 2025 [11] Financial Position - As of March 31, 2025, total cash and cash equivalents decreased to $5.2 billion from $6.2 billion at the end of 2024 [8] - Total assets increased to $120.3 billion from $117.6 billion at the end of 2024 [8] - Adjusted debt increased to $7.5 billion from $7.2 billion at the end of 2024, with a debt to adjusted capitalization ratio of 20.7% [9] Future Outlook - Aflac anticipates improved sales in its Japan business for 2025, focusing on third-sector products and targeting younger customers [12] - The company expects a benefit ratio of 64-66% for Aflac Japan and 48-52% for Aflac U.S. in 2025 [13]

本报记者 冷翠华 见习记者 杨笑寒 国家金融监督管理总局近日披露了一季度保险业原保险保费收入（以下简称为"保费收入"）情况。数据显示，今年一季 度，保险业实现保费收入2.17万亿元，同比微增。其中，财产险公司保费收入同比稳健增长，人身险公司保费收入同比微降， 有所分化。 受访专家表示，不同类型的险企保费收入增速分化主要受到行业步入转型期、人身险产品销售结构调整等因素影响。随着 市场需求的逐步释放和行业转型的深入推进，保险业有望实现高质量发展。 健康险保费增速亮眼 受行业发展转型、产品销售结构调整等因素影响，一季度人身险公司与财险公司的保费收入有所分化。 数据显示，今年一季度，保险业实现保费收入21745亿元，同比增长0.93%。其中，财产险公司实现保费收入5155亿元，同 比增长5.10%；人身险公司实现保费收入16590亿元，同比下降0.29%。 对此，普华永道管理咨询（上海）有限公司中国金融行业管理咨询合伙人周瑾对《证券日报》记者表示，对于人身险公司 而言，险企今年一季度销售整体面临较大挑战，一方面是因为行业为了应对市场利率下行而主动调整产品策略，加大浮动收益 类产品的占比，产品对消费者的吸引力有所下降， ...

阿根廷农业部数据显示，阿根廷农民的大豆销售速度创下11年来最慢水平。 ...